Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
Similar Posts
Jamie Foxx Is Recovering After Being Hospitalized For A “Medical Complication”
Jamie Foxx is currently recovering from an unspecified medical emergency that reportedly hospitalized him. On Wednesday, Corinne Foxx, the daughter of the Oscar-winning actor, posted a statement to Instagram on behalf of the Foxx family that said he had “experienced a medical complication” the day prior. “Luckily, due to quick action and great care, he…
Democrats Have A $50 Billion Plan To Ease U.S. Nurse ‘Shortage’
Congressional Democrats want to pump $50 billion into the training and hiring of more public health nurses ― a cash infusion they say would improve both working conditions for nurses and health outcomes for underserved communities. Lawmakers planned to introduce bills in both the House and Senate on Wednesday to establish a grant program for…
Cold weather: What does an unheated room do to your body?
The BBC’s health and science correspondent undergoes an experiment to find out how a cold home affects him.
COVID infections on the rise as new year begins
COVID infections on the rise as new year begins – CBS News Watch CBS News A rise in COVID-19 infections has prompted at least five states to reinstate mask requirements at health care facilities. Elise Preston reports. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now…
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
Eli Lilly launches website to help patients get weight loss drugs
Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a move, the company says, that will improve access to the extremely popular and effective drugs, including its recently approved drug, Zepbound. The new website, called LillyDirect, joins a growing list of platforms like Weight…
